ISTA Pharmaceuticals Revised Payment and Performance Schedule (Amendments 2 & 3)
Contract Categories:
Business Operations
›
Services Agreements
Summary
This document outlines the revised payment and performance schedule for a clinical study managed by ISTA Pharmaceuticals, reflecting changes from Amendments 2 and 3. It details updated costs, visit schedules, and adjustments for site recruitment, regulatory submissions, and monitoring visits across Canada, the U.S., and Australia. The schedule specifies increased visit rates and additional monitoring due to expanded patient populations and protocol changes, as well as the removal or addition of certain site visits. The agreement ensures all parties are aware of the revised financial and operational commitments for the study.
EX-10.26 3 a80129ex10-26.txt EXHIBIT 10.26 Exhibit 10.26 ISTA PHARMACEUTICALS ATTACHMENT 2 - REVISED PAYMENT AND PERFORMANCE SCHEDULE
ISTA PHARMACEUTICALS ATTACHMENT 2 - REVISED PAYMENT AND PERFORMANCE SCHEDULE
ISTA PHARMACEUTICALS ATTACHMENT 2 - REVISED PAYMENT AND PERFORMANCE SCHEDULE